These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16705207)

  • 1. Misleading conclusions on rt-PA treatment in the very elderly.
    Vroomen PC; Uyttenbogaart M; Luijckx GJ
    J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):799; author reply 799. PubMed ID: 16705207
    [No Abstract]   [Full Text] [Related]  

  • 2. Age and Stroke Severity: Hazards for Intravenous Thrombolysis?
    Long C; Li M
    Med Princ Pract; 2016; 25(1):99-100. PubMed ID: 26457894
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years.
    Mione G; Ducrocq X; Thilly N; Lacour JC; Vespignani H; Richard S
    Geriatr Gerontol Int; 2016 Jul; 16(7):843-9. PubMed ID: 26245693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHADS2 score is associated with 3-month clinical outcomes after intravenous rt-PA therapy in stroke patients with atrial fibrillation: SAMURAI rt-PA Registry.
    Koga M; Kimura K; Shibazaki K; Shiokawa Y; Nakagawara J; Furui E; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Naganuma M; Nezu T; Maeda K; Minematsu K; Toyoda K
    J Neurol Sci; 2011 Jul; 306(1-2):49-53. PubMed ID: 21492878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation.
    Lawson TR; Brown IE; Westerkam DL; Blackhurst DW; Sternberg S; Leacock R; Nathaniel TI
    Restor Neurol Neurosci; 2015; 33(3):301-8. PubMed ID: 25698111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Ischemic Stroke with Very Early Clinical Improvement: A National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trials Exploratory Analysis.
    Balucani C; Levine SR; Khoury JC; Khatri P; Saver JL; Broderick JP
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):894-901. PubMed ID: 26825352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple clinical predictors of stroke outcome based on National Institutes of Health Stroke scale score during 1-h recombinant tissue-type plasminogen activator infusion.
    Osaki M; Miyashita F; Koga M; Fukuda M; Shigehatake Y; Nagatsuka K; Minematsu K; Toyoda K
    Eur J Neurol; 2014 Mar; 21(3):411-8. PubMed ID: 24200315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing use of intravenous rt-PA does not affect safety in acute stroke.
    Pfefferkorn T; Liebetrau M; Müllner A; Bender A; Hamann GF
    J Neurol; 2005 Dec; 252(12):1500-3. PubMed ID: 16021352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating the elderly stroke patient: complications, controversies, and best care metrics.
    Heitsch LE; Panagos PD
    Clin Geriatr Med; 2013 Feb; 29(1):231-55. PubMed ID: 23177609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truths about the NINDS study: setting the record straight.
    Mann J
    West J Med; 2002 May; 176(3):192-4. PubMed ID: 12016245
    [No Abstract]   [Full Text] [Related]  

  • 11. A hundred (and one) graphs tell only part of the story.
    Silbergleit R
    Ann Emerg Med; 2009 Sep; 54(3):342-3. PubMed ID: 19695418
    [No Abstract]   [Full Text] [Related]  

  • 12. tPA for acute stroke: balancing baseline imbalances.
    Mann J
    CMAJ; 2002 Jun; 166(13):1651-2; author reply 1652-3. PubMed ID: 12126317
    [No Abstract]   [Full Text] [Related]  

  • 13. [ASPECTS-DWI, arterial occlusion sites and subtype of acute ischemic stroke have a relation with outcome following intravenous rt-PA therapy].
    Idei M; Sasaki T; Tanabe T; Muraoka K; Terada K; Meguro T; Hirotsune N; Nishino S
    No Shinkei Geka; 2012 Jul; 40(7):585-91. PubMed ID: 22728535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with the administration of tissue plasminogen activator for acute ischemic stroke.
    Kunisawa S; Kobayashi D; Lee J; Otsubo T; Ikai H; Yokota C; Minematsu K; Imanaka Y
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):724-31. PubMed ID: 23910512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA: SAMURAI rt-PA Registry.
    Nezu T; Koga M; Kimura K; Shiokawa Y; Nakagawara J; Furui E; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Nishiyama K; Naganuma M; Minematsu K; Toyoda K
    Neurology; 2010 Aug; 75(6):555-61. PubMed ID: 20697108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of First Recorded "Last Known Normal" Times of Stroke Code Patients.
    Spokoyny I; Raman R; Ernstrom K; Kim AJ; Meyer BC; Karanjia NP
    J Stroke Cerebrovasc Dis; 2015 Nov; 24(11):2467-73. PubMed ID: 26341734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke thrombolysis in England: an age stratified analysis of practice and outcome.
    Bray BD; Campbell J; Hoffman A; Tyrrell PJ; Wolfe CD; Rudd AG
    Age Ageing; 2013 Mar; 42(2):240-5. PubMed ID: 23174425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Established treatments for acute ischaemic stroke.
    Khaja AM; Grotta JC
    Lancet; 2007 Jan; 369(9558):319-30. PubMed ID: 17258672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Interventional Management of Stroke (IMS) II Study.
    IMS II Trial Investigators
    Stroke; 2007 Jul; 38(7):2127-35. PubMed ID: 17525387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.